Of note, while three cases with MUTYH variants had high TMB, we attributed it to MMR deficiency in the tumor due to MLH1 methylation or deletion of MSH2, supported by high MSI levels and MMR-deficient mutational signatures. This evidence concerns the gene MSH2 and hyperinsulinemic hypoglycemia, familial, 4.